Yahoo
OTC Markets OTCQX - Delayed Quote USD

Microbix Biosystems Inc. (MBXBF)

0.2080 -0.0120 (-5.45%)
At close: October 30 at 4:00:00 PM EDT
View in AlphaSpace Currency in CAD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
9/30/2025
9/30/2024
9/30/2023
9/30/2022
Total Revenue
15,400.2380
18,585.3660
25,394.1480
16,514.7760
19,076.2410
Cost of Revenue
8,332.1580
8,731.7960
10,002.4470
9,033.4420
7,951.3990
Gross Profit
7,068.0790
9,853.5700
15,391.7010
7,481.3340
11,124.8420
Operating Expense
11,344.7890
11,429.7240
11,494.9260
10,217.7660
8,514.6290
Operating Income
-4,276.7100
-1,576.1540
3,896.7750
-2,736.4320
2,610.2130
Net Non Operating Interest Income Expense
-753.9710
-595.8940
-234.2690
-381.6360
-744.2900
Other Income Expense
90.0170
-129.4900
8.2370
3,078.5850
--
Pretax Income
-4,940.6640
-2,301.5380
3,670.7420
-39.4830
1,865.9230
Tax Provision
--
-55.7260
150.5630
0
77.2340
Net Income Common Stockholders
-4,884.9380
-2,245.8120
3,520.1790
-39.4830
1,788.6890
Diluted NI Available to Com Stockholders
-4,884.9380
-2,245.8120
3,520.1790
-39.4830
1,788.6890
Basic EPS
-0.04
-0.02
0.03
0.00
0.01
Diluted EPS
-0.04
-0.02
0.03
0.00
0.01
Basic Average Shares
137,911.2160
139,153.6660
137,697.6600
137,911.8840
135,376.2550
Diluted Average Shares
137,911.2160
139,153.6660
138,490.8480
137,911.8840
141,688.2490
Total Operating Income as Reported
--
-1,705.6440
3,905.0110
-2,736.4320
2,610.2130
Total Expenses
19,676.9470
20,161.5200
21,497.3730
19,251.2080
16,466.0280
Net Income from Continuing & Discontinued Operation
-4,884.9380
-2,245.8120
3,520.1790
-39.4830
1,788.6890
Normalized Income
-4,974.9550
-2,119.4573
3,512.2799
-3,118.0680
1,788.6890
Interest Income
258.3290
354.5180
687.5060
457.7420
82.2700
Interest Expense
1,012.3000
950.4120
921.7750
839.3780
826.5600
Net Interest Income
-753.9710
-595.8940
-234.2690
-381.6360
-744.2900
EBIT
-3,928.3640
-1,351.1260
4,592.5170
799.8950
2,692.4830
EBITDA
-2,065.3280
428.2300
6,205.3300
1,957.0640
3,728.8830
Reconciled Cost of Revenue
8,332.1580
8,731.7960
10,002.4470
8,037.5170
7,075.3430
Reconciled Depreciation
1,863.0360
1,779.3560
1,612.8130
1,157.1690
1,036.4000
Net Income from Continuing Operation Net Minority Interest
-4,884.9380
-2,245.8120
3,520.1790
-39.4830
1,788.6890
Total Unusual Items Excluding Goodwill
90.0170
-129.4900
8.2370
3,078.5850
0
Total Unusual Items
90.0170
-129.4900
8.2370
3,078.5850
0
Normalized EBITDA
-2,155.3450
557.7200
6,197.0930
-1,121.5210
3,728.8830
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
-3.1353
0.3379
0
0
9/30/2022 - 1/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: